Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-structural protein 4 (NSP4) is a multifunctional viral protein most notably characterized as the first recognized viral enterotoxin, primarily associated with Rotavirus. In Rotavirus, it functions as a viroporin that disrupts host calcium homeostasis by inducing the release of calcium from the endoplasmic reticulum into the cytoplasm, which triggers a cascade leading to secretory diarrhea and facilitates viral morphogenesis [3, 51, 61]. Beyond Rotavirus, NSP4 (or nsp4) is also a critical component of the replication machinery in other viruses, such as SARS-CoV-2, where it interacts with NSP3 to remodel host cell membranes into double-membrane vesicles (DMVs) that serve as protected sites for viral RNA synthesis [5, 11, 44]. As a therapeutic target, NSP4 is being explored for the development of antivirals that can mitigate symptoms of severe gastroenteritis or inhibit the replication of coronaviruses. Small molecule inhibitors like STF-3577 have shown promise in blocking NSP4-mediated membrane rearrangements in SARS-CoV-2, while experimental ion channel blockers and probiotics like Saccharomyces boulardii are investigated for their ability to neutralize the enterotoxigenic effects of Rotavirus NSP4 [49, 61, 74]. Given its essential role in both viral pathogenesis and the replication cycle, NSP4 represents a high-value target for broad-spectrum and virus-specific antiviral strategies.
Inhibition of viroporin-mediated calcium release from the endoplasmic reticulum, disruption of enterotoxin-induced signaling pathways, and prevention of viral replication organelle formation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-structural protein 4 (NSP4).